|Mr. James C. Clemmer||CEO, Pres & Director||957.51k||N/A||1964|
|Mr. Michael C. Greiner||Exec. VP & CFO||542.59k||N/A||1973|
|Mr. David D. Helsel||Sr. VP of Global Operations and R&D||280.41k||N/A||1964|
|Mr. Stephen A. Trowbridge||Sr. VP & Gen. Counsel||419.27k||N/A||1974|
|Mr. Robert A. Simpson||Sr. VP & GM of Vascular Interventions and Therapies||516.57k||N/A||1972|
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company provides AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support. It also offers thrombolytic catheters to deliver thrombolytic agents; angiographic products and accessories for use in during peripheral vascular interventional procedures; drainage products, which drain abscesses and other fluid pockets; and micro access sets. In addition, the company provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products to treat superficial venous diseases; and Asclera injection for treating uncomplicated spider and reticular veins of the lower extremities. Further, it provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation system; and radiofrequency ablation products for ablating solid cancerous or benign tumors. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.
AngioDynamics, Inc.’s ISS Governance QualityScore as of April 1, 2019 is 3. The pillar scores are Audit: 3; Board: 3; Shareholder Rights: 5; Compensation: 1.